Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson

Araverus Team|Thursday, February 12, 2026 at 7:42 AM

Araverus Team

Feb 12, 2026 · 7:42 AM

BeléN Garijo · CEO Change · Pharmaceuticals · Sanofi

BeléN Garijo CEO Change Pharmaceuticals Sanofi

Sanofi has appointed Belén Garijo, the CEO of Merck KGaA, as its new chief executive following the decision not to renew Paul Hudson's mandate, amid investor concerns and declining vaccine demand.

Read More On

Sanofi Names Merck KGaA’s Garijo to Replace Hudson as CEOwsj.com

Sanofi appoints Belén Garijo as new CEO after deciding not to renew Hudson’s mandate By Reuters - Investing.cominvesting.com

Sanofi Picks Belén Garijo As CEO After Hudson Exit - Finimizefinimize.com

BREAKING: Sanofi Replaces CEO Paul Hudson With Merck KGaA’s Belén Garijo - Citeline News & Insightsinsights.citeline.com

Sanofi appoints Belén Garijo as new CEO after deciding not to renew Hudson’s mandate - SRN Newssrnnews.com

Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson

Read More On

Related Articles

Sanofi Stock Dives 5% as Garijo Replaces Hudson Amid Performance Slump

Kroger Appoints Former Walmart Executive Greg Foran CEO to Navigate Market Challenges

Kroger Appoints Former Walmart Executive Foran to Lead Expansion, Tackle Consumer Spending Woes

Toyota Elevates CFO Kenta Kon to CEO, Investors Eye Second Leadership Shift in Three Years

Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson

Read More On

Related Articles

Sanofi Stock Dives 5% as Garijo Replaces Hudson Amid Performance Slump

Kroger Appoints Former Walmart Executive Greg Foran CEO to Navigate Market Challenges

Kroger Appoints Former Walmart Executive Foran to Lead Expansion, Tackle Consumer Spending Woes

Toyota Elevates CFO Kenta Kon to CEO, Investors Eye Second Leadership Shift in Three Years